Exploring upper-limb tests for cardiopulmonary function assessment

How can inclusivity be achieved in cardiopulmonary exercise tests for individuals facing lower limb injuries or disabilities that make it impossible to pedal a bicycle?

Amivantamab by Johnson & Johnson for Colorectal Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

August 30, 2023

Mental Health Parity Rule Lauded by Healthcare Groups

Reviews were generally positive for the final version of the mental health parity rule that the Biden administration released on Monday. “The Mental Health Parity

September 13, 2024

Catalyst licenses Santhera Pharmaceuticals’ vamorolone

Vamorolone has received orphan drug status in the US to treat Duchenne muscular dystrophy. Credit: StudioMolekuul / shutterstock.com. Santhera Pharmaceuticals and Catalyst Pharmaceuticals have signed

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.